Fig. 3

Distribution of SARS-CoV-2 neutralizing antibody. A Per-protocol analysis, B intention-to-treat analysis. The table shows the percentages of SARS-CoV-2 neutralizing antibody in each group
Distribution of SARS-CoV-2 neutralizing antibody. A Per-protocol analysis, B intention-to-treat analysis. The table shows the percentages of SARS-CoV-2 neutralizing antibody in each group